Praxis Precision Medicines, Inc.PRAXNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank29
3Y CAGR-42.9%
5Y CAGR-50.9%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-42.9%/yr
Annual compound
5Y CAGR
-50.9%/yr
Recent acceleration
Percentile
P29
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 4.93% |
| 2024 | 33.89% |
| 2023 | -29.38% |
| 2022 | 26.49% |
| 2021 | 177.04% |
| 2020 | 172.66% |
| 2019 | 59.84% |
| 2018 | 0.00% |